HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between Peptidylarginine Deiminase Type 4 rs1748033 Polymorphism and Susceptibility to Rheumatoid Arthritis in Zahedan, Southeast Iran.

Abstract
There are controversial reports regarding the role of peptidylarginine deiminase type 4 (PADI4) gene polymorphisms and risk of Rheumatoid arthritis (RA). The aim of the present study was to investigate the impact of PADI4 rs1748033 polymorphism and susceptibility to RA in a sample of the Iranian population. This case-control study was done on 150 patients with RA and 150 healthy subjects.PADI4 rs1748033 genotyping was done using amplification refractory mutation system- polymerase chain reaction (ARMS-PCR) assay. The PADI4 rs1748033 variant increased the risk of RA in codominant (OR=1.67, 95%CI=1.03-2.71, p=0.048, CT vs CC; OR=2.73, 95%CI=1.25-5.97, p=0.013, TT vs CC) and dominant (OR=1.84, 95%CI=1.15-2.92, p=0.014, CT+TT vs CC) tested inheritance models. In addition, the PADI4 rs1748033 T allele increased the risk of RA (OR=1.63, 95%CI=1.16-2.29, p=0.006) in comparison with C allele. In conclusion, our finding indicated that PADI4 rs1748033 gene polymorphism increased the risk of RA in a sample of the Iranian population.
AuthorsMohammad Hashemi, Zahra Zakeri, Hamed Taheri, Gholamreza Bahari, Mohsen Taheri
JournalIranian journal of allergy, asthma, and immunology (Iran J Allergy Asthma Immunol) Vol. 14 Issue 3 Pg. 255-60 (Jun 2015) ISSN: 1735-1502 [Print] Iran
PMID26546893 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hydrolases
  • PADI4 protein, human
  • Protein-Arginine Deiminase Type 4
  • Protein-Arginine Deiminases
Topics
  • Adult
  • Arthritis, Rheumatoid (genetics)
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Hydrolases (genetics)
  • Male
  • Middle Aged
  • Polymorphism, Genetic
  • Protein-Arginine Deiminase Type 4
  • Protein-Arginine Deiminases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: